Biomolecules capturing live bacteria from clinical samples.

Sorgenfrei, Michèle; Hürlimann, Lea M; Remy, Mélissa M; Keller, Peter Michael; Seeger, Markus A (2022). Biomolecules capturing live bacteria from clinical samples. Trends in biochemical sciences, 47(8), pp. 673-688. Elsevier Current Trends 10.1016/j.tibs.2022.03.018

Text 1-s2.0-S0968000422000779-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB)

Rapid phenotypic antimicrobial susceptibility testing (AST) requires the enrichment of live bacteria from patient samples, which is particularly challenging in the context of life-threatening bloodstream infections (BSIs) due to low bacterial titers. Over two decades, an extensive array of pathogen-specific biomolecules has been identified to capture live bacteria. The prevailing biomolecules are immune proteins of the complement system, antibodies, aptamers, phage proteins, and antimicrobial peptides. These biomolecules differ by their binder generation technologies and exhibit highly variable specificities, ranging from bacterial strains to most pathogenic bacteria. Here, we summarize how these diverse biomolecules were identified, list examples of successfully reported capture assays, and provide an outlook on the use of nanobodies raised against conserved surface-accessible proteins as promising biomolecules for pathogen capture.

Interest & Impact

Downloads

2 since deposited on 02 May 2022
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item